Literature DB >> 9406062

Comparison and variation of different methodologies for the detection of autoantibodies to nuclear antigens (ANA).

C González1, T Martin, T Arroyo, M García-Isidoro, J A Navajo, J M González-Buitrago.   

Abstract

Interest in the assessment of autoantibody specificity stems from the need for an autoantibody marker capable of predicting clinical events in autoimmune disorders. However, the multiplicity of epitopes present on autoantigenic particles, the quantitative and qualitative heterogeneity of autoantibodies, as well as the nature of the tests, mean that each of the assays used in their determination have different characteristics. The aim of this study was to compare the specificities of different ANAs using four commercial assays. The routine method used for the detection of ANA is indirect immunofluorescence on Hep-2 cells. The assays used were: counterimmunoelectrophoresis (CIE), enzyme-linked immunosorbent assay (ELISA), and two immunoblotting assays. Kappa statistic was applied to evaluate the consistency between tests. Kappa index is a measure of agreement between categorical data. Kappa has a maximum of 1.00 when the agreement is perfect, a value of zero indicates no agreement better than chance, and negative values show worse than chance agreement. For SS-B antibodies, there was a good concordance between all four methods used (Kappa 0.66-0.74). For anti RNP antibodies, the results for CIE/ELISA (Kappa 0.60) were consistent as were the two immunoblot methods (Kappa 0.69). For anti Scl-70 (topoisomerase I) antibody, results from the ELISA and CIE methods were totally consistent (Kappa 1.00). In spite of the high prevalence of anti SS-A/Ro antibodies, the agreement between the methods was poor, without statistical significance. Finally, for Sm antibodies, more consistent results were obtained between CIE/ELISA (Kappa 0.51) and between one of the immunoblotting methods and ELISA (Kappa 0.54). In conclusion, CIE concurs mostly with ELISA for anti-RNP, Scl-70, Sm and SS-B antibodies, but with some disagreement for SS-A antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406062      PMCID: PMC6760727     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  13 in total

Review 1.  Molecular biology of nuclear autoantigens.

Authors:  M R Saitta; J D Keene
Journal:  Rheum Dis Clin North Am       Date:  1992-05       Impact factor: 2.670

2.  Partial purification and characterization of an extractible nuclear antigen which reacts with SLE sera.

Authors:  H R Holman
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

3.  The presence of antibodies against extractable nuclear antigens in serum: a comparison of immunoblotting versus radial immunodiffusion.

Authors:  W Uyttenbroeck; W Cooreman; S Scharpe
Journal:  Ann Clin Biochem       Date:  1993-01       Impact factor: 2.057

Review 4.  Current status of available standards for quality improvement of assays for detection of autoantibodies to nuclear and intracellular antigens.

Authors:  R M Nakamura; D J Bylund; E M Tan
Journal:  J Clin Lab Anal       Date:  1994       Impact factor: 2.352

5.  Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Authors:  B Combe; M Rucheton; H Graafland; V Lussiez; C Brunel; J Sany
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

6.  Human autoantibodies directed against the RNA recognition motif of La (SS-B) bind to a conformational epitope present on the intact La (SS-B)/Ro (SS-A) ribonucleoprotein particle.

Authors:  M Rischmueller; L J McNeilage; J McCluskey; T Gordon
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

7.  Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein.

Authors:  Y Itoh; M Reichlin
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

Review 8.  The Consensus Workshops for the Detection of Autoantibodies to Intracellular Antigens in Rheumatic Diseases: 1989-1992.

Authors:  P J Charles; W J van Venrooij; R N Maini
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

9.  Antinuclear antibodies in routine analysis: the relevance of putative clinical associations.

Authors:  A J Swaak; V Huysen; R J Smeenk
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

10.  Characterization of murine monoclonal antibodies against 60-kD Ro/SS-A and La/SS-B autoantigens.

Authors:  C H Veldhoven; G J Pruijn; J F Meilof; J P Thijssen; A W Van der Kemp; W J Van Venrooij; R J Smeenk
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

View more
  2 in total

1.  Determination of cut-off titers and agreement between immunofluorescence and immunoblotting methods for detecting antinuclear antibodies in children.

Authors:  G Aksu; N Gulez; E Azarsiz; N Karaca; N Kutukçuler
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  RNA recognition motif (RRM) of La/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP.

Authors:  John G Routsias; Nikolaos Kyriakidis; Michael Latreille; Athanasios G Tzioufas
Journal:  Mol Med       Date:  2009-10-14       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.